Incorporating Commercial and Private Data
by: Carole Goble, AlasdairJ Gray, Lee Harland, Karen Karapetyan, Antonis Loizou, Ivan Mikhailov, Yrjänä Rankka, Stefan Senger, Valery Tkachenko, AntonyJ Williams, EgonL Willighagen
Edited by: Harith Alani, Lalana Kagal, Achille Fokoue, Paul Groth, Chris Biemann, JosianeXavier Parreira, Lora Aroyo, Natasha Noy, Chris Welty, Krzysztof Janowicz
ABSTRACT
The Open PHACTS Discovery Platform aims to provide an integrated information space to advance pharmacological research in the area of drug discovery. Effective drug discovery requires comprehensive data coverage, i.e. integrating all available sources of pharmacology data. While many relevant data sources are available on the linked open data cloud, their content needs to be combined with that of commercial datasets and the licensing of these commercial datasets respected when providing access to the data. Additionally, pharmaceutical companies have built up their own extensive private data collections that they require to be included in their pharmacological dataspace. In this paper we discuss the challenges of incorporating private and commercial data into a linked dataspace: focusing on the modelling of these datasets and their interlinking. We also present the graph-based access control mechanism that ensures commercial and private datasets are only available to authorized users.
To read FULL ARTICLE click on one of the links:
DOI, SpringerLink